Richard Blyton Devereux, M.D.

Cardiovascular Disease
Richard Devereux

Doctor Devereux is Director of the Adult Echocardiography Laboratory at the Weill Cornell Center of the New York Presbyterian Hospital. He has a long-standing clinical and research interest in cardiovascular connective tissue diseases, and has served as Chair of the Professional Advisory Committee of the National Marfan Froundation. In addition to expertise in all aspects of clinical echocardiography, Dr. Devereux conducts extensive research using cardiac ultrasound and other techniques to improve understanding of hypertensive heart disease, valvular heart diseases, cardiac effects of obesity diabetes, the prevalence and mechanisms of cardiovascular diseases in population-based samples and identify genes linked to and potentially responsible for a spectrum of cardiovascular diseases.

A summary of Dr. Devereux's Education, Training and/or Faculty Appointments is listed as following:

1971   M.D. - University of Pennsylvania School of Medicine

1972   Intern, Internal Medicine - New York and Memorial Hospitals

1974   Resident, Internal Medicine - New York and Memorial Hospitals

1976   Fellow, Cardiology - Hospital of the University of Pennsylvania

Insurances

Insurance Plans Accepted

The following represents most of the managed care plans accepted by this physician. If your insurance carrier does not appear here please feel free to contact this physician or this physician's practice as they may have individual contracts not included on this site.

  • AETNA [Medicare]
  • AETNA [PPO]
  • AETNA [HMO]
  • Aetna - Weill Cornell [POS]
  • Affinity Health Plan
  • CIGNA
  • Empire Blue Cross/Blue Shield [EPO]
  • Empire Blue Cross/Blue Shield [HMO]
  • Empire Blue Cross/Blue Shield [Mediblue (Senior)]
  • Empire Blue Cross/Blue Shield [PPO]
  • Fidelis Care
  • GHI [CBP]
  • Health First
  • Health Insurance Plan of NY (HIP) [Medicare]
  • Health Insurance Plan of NY (HIP) [Medicaid]
  • Health Insurance Plan of NY (HIP)
  • Health Plus - Amerigroup
  • Medicare [Medicare]
  • Oxford Health Plans [Medicare Advantage]
  • Oxford Health Plans [Freedom]
  • Oxford Health Plans [Liberty]
  • Rockefeller University - CoreSource
  • United Empire
  • United Health Care
  • United Health Care [Medicare]
  • United Health Care [Community Plan]

Publications


  • Devereux RB, Roman MJ, Liu JE, Lee ET, Wang W, Fabsitz RR, Welty TK, Howard BV: An appraisal of echocardiography as an epidemiological tool: The Strong Heart Study Ann Epidemiol 2003;13:238-244.
  • Palmieri V, Okin PM, Bella JN, Gerdts E, Wachtell K, Gardin J, Papademetriou V, Nieminen MS, Dahlöf B, Devereux RB: Echocardiographic wall motion abnormalities in hypertensive patients with electrocardiographic left ventricular hypertrophy: The LIFE Study. Hypertension 2003;41:75-82.
  • Palmieri V, Celentano A, Roman MJ, de Simone G, Best L, Robbins DC, Fabsitz RR, Howard BV, Devereux RB: Relation of fibrinogen to cardiovascular events is independent of preclinical cardiovascular disease: The Strong Heart Study. Am Heart J 2003;145:467-474.
  • Oikarinen L, Nieminen MS, Toivonen, Viitasalo M, Wachtell K, Papademetriou V, Jern S, Dahlöf B, Devereux RB, Okin PM, for the LIFE study investigators: Relation of QT interval and QT dispersion to regression of echocardiographic and electrocardiographic left ventricular hypertrophy in hypertensive patients. Am Heart J 2003;145:919-925.
  • Okin PM, Devereux RB, Jern S, Kjeldsen SE, Julius S, Nieminen MS, Snapinn S, Harris KE, Aurup P, Edelman JM, Dahlof B for the LIFE Study investigators: Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: The LIFE study. Circulation 2003;108:684-690.
  • Palmieri V, Bella JN, Oberman A, Kitzman DW, Hopkins PN, Rao DC, Roman MJ, Devereux RB: Associations of aortic and mitral regurgitation with body composition and myocardial energy expenditure in adults with hypertension: The Hypertension Genetic Epidemiology Network study. Am Heart J 2003;145:1071-1077.
  • Aurigemma GP, Devereux RB, Wachtell K, Palmieri V, Boman K, Gerdts E, Nieminen MS, Papademetriou V, Dahlöf B: Should previously-treated hypertensive patients be enrolled in clinical trials of left ventricular mass regression? The LIFE Study. Am J Hypertens 2003;16:180-186.
  • Wachtell K, Ibsen H, Olsen MH, Borch-Johnsen K, Lindholm LH, Mogensen CE, Dahlöf B, Devereux RB, Beevers F, de Faire U, Fyhrquist F, Julius S, Kjeldsen AE, Kristianson K, Lederballe-Pedersen O, Nieminen MS, Okin PM, Omvik P, Oparil S, Wedel H, Aurup P: Does albuminuria increase cardiovascular risk in hypertensive patients with left ventricular hypertrophy? The LIFE Study. Ann Intern Med 2003;139:901-906.
  • Palmieri V, Bella JN, Roman MJ, Gerdts E, Papademetriou V, Wachtell K, Nieminen MS, Dahlöf B, Devereux RB: Pulse pressure/stroke index and left ventricular geometry and function: The LIFE study. J Hypertens 2003;21:781-787.
  • Schaffer WL, Galloway JM, Roman MJ, Palmieri V, Liu JE, Lee ET, Fabsitz RR, Howard BV, Devereux RB: Prevalence and correlates of rheumatic heart disease in American Indians: The Strong Heart Study. Am J Cardiol 2003;91:1379-1382.
  • Devereux RB, Roman MJ, Palmieri V, Liu JE, Lee ET, Best LG, Fabsitz RR, Rodeheffer RJ, Howard BV: Prognostic implications of ejection fraction from linear echocardiographic dimensions: The Strong Heart Study. Am Heart J 2003;146:527-534.
  • Devereux RB, Dahlöf B, Kjeldsen SE, Julius S, Aurup P, Beevers G, Edelman JM, de Faire U, Fyhrquist F, Berg SH, Ibsen H, Kristianson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Snapinn SM, Wedel H, for the LIFE study group: Cardiovascular morbidity and mortality in patients without pre-existing vascular disease in the Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study. Ann Intern Med 2003;139:169-177.
  • de Simone G, Devereux RB, Palmieri V, Bella JN, Oberman A, Kitzman DW, Hopkins PN, Rao DC, Arnett DK: Influence of fat-free mass on detection of appropriateness of left ventricular mass: The HyperGEN study. J Hypertens 2003;21:1747-1752.
  • Liu JE, Robbins DC, Palmieri V, Bella JN, Roman MJ, Fabsitz R, Howard BV, Welty TK, Lee ET, Devereux RB: Association of albuminuria with systolic and diastolic left ventricular dysfunction in type 2 diabetes: The Strong Heart Study. J Am Coll Cardiol 2003;41:2022-2028.
  • Palmieri V, Tracey RP, Roman MJ, Liu JE, Best LG, Bella JN, Robbins DC, Howard BV, Devereux RB: Relations of left ventricular hypertrophy to inflammation and albuminuria in adults with type 2 diabetes: The Strong Heart Study. Diabetes Care 2003;26:2764-2769.
  • Kristianson K, Fyhrquist F, Devereux RB, Kjeldsen SE, Lindholm LH, Lyle PA, Nieminen MS, Snapinn SM: An analysis of cholesterol control and statin use in the Losartan Intervention for Endpoint Reduction in Hypertension study. Clinical Therapeutics 2003;25:1186-1199.
  • Roman MJ, Shanker BA, Davis A, Lockshin MD, Sammaritano L, Simantov R, Crow MK, Schwartz JE, Paget SA, Devereux RB, Salmon JE: Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med 2003;349:2399-2406.
  • Tang W, Devereux RB, Kitzman DW, Province MA, Leppert M, Oberman A, Hopkins PN, Arnett DK: The Arg17Gly polymorphism of the beta2-adrenergic receptor and left ventricular systolic function. Am J Hypertens 2003;16:945-951.
  • Palmieri V, Okin PM, Bella JN, Gerdts E, Wachtell K, Gardin J, Papademetriou V, Nieminen MS, Dahlöf B, Devereux RB: Echocardiographic wall motion abnormalities in hypertensive patients with electrocardiographic left ventricular hypertrophy: The LIFE Study. Hypertension 2003;41:75-82.
  • Palmieri V, Celentano A, Roman MJ, de Simone G, Best L, Robbins DC, Fabsitz RR, Howard BV, Devereux RB: Relation of fibrinogen to cardiovascular events is independent of preclinical cardiovascular disease: The Strong Heart Study. Am Heart J 2003;145:467-474.
  • Oikarinen L, Nieminen MS, Toivonen, Viitasalo M, Wachtell K, Papademetriou V, Jern S, Dahlöf B, Devereux RB, Okin PM, for the LIFE study investigators: Relation of QT interval and QT dispersion to regression of echocardiographic and electrocardiographic left ventricular hypertrophy in hypertensive patients. Am Heart J 2003;145:919-925.
  • Okin PM, Devereux RB, Jern S, Kjeldsen SE, Julius S, Nieminen MS, Snapinn S, Harris KE, Aurup P, Edelman JM, Dahlof B for the LIFE Study investigators: Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: The LIFE study. Circulation 2003;108:684-690.
  • Palmieri V, Bella JN, Oberman A, Kitzman DW, Hopkins ON, Rao DC, Roman MJ, Devereux RB: Associations of aortic and mitral regurgitation with body composition and myocardial energy expenditure in adults with hypertension: The Hypertension Genetic Epidemiology Network study. Am Heart J 2003;145:1071-1077.
  • Aurigemma GP, Devereux RB, Wachtell K, Palmieri V, Boman K, Gerdts E, Nieminen MS, Papademetriou V, Dahlöf B: Should previously-treated hypertensive patients be enrolled in clinical trials of left ventricular mass regression? The LIFE Study. Am J Hypertens 2003;16:180-186.
  • Wachtell K, Ibsen H, Olsen MH, Borch-Johnsen K, Lindholm LH, Mogensen CE, Dahlöf B, Devereux RB, Beevers F, de Faire U, Fyhrquist F, Julius S, Kjeldsen AE, Kristianson K, Lederballe-Pedersen O, Nieminen MS, Okin PM, Omvik P, Oparil S, Wedel H, Aurup P: Does albuminuria increase cardiovascular risk in hypertensive patients with left ventricular hypertrophy? The LIFE Study. Ann Intern Med 2003;139:901-906.
  • Palmieri V, Bella JN, Roman MJ, Gerdts E, Papademetriou V, Wachtell K, Nieminen MS, Dahlöf B, Devereux RB: Pulse pressure/stroke index and left ventricular geometry and function: The LIFE study. J Hypertens 2003;21:781-787.
  • Schaffer WL, Galloway JM, Roman MJ, Palmieri V, Liu JE, Lee ET, Fabsitz RR, Howard BV, Devereux RB: Prevalence and correlates of rheumatic heart disease in American Indians: The Strong Heart Study. Am J Cardiol 2003;91:1379-1382.
  • Devereux RB, Roman MJ, Palmieri V, Liu JE, Lee ET, Best LG, Fabsitz RR, Rodeheffer RJ, Howard BV: Prognostic implications of ejection fraction from linear echocardiographic dimensions: The Strong Heart Study. Am Heart J 2003;146:527-534.
  • de Simone G, Devereux RB, Palmieri V, Roman MJ, Celentano A, Welty TK, Fabsitz RR, Contaldo F, Howard BV for the Strong Heart Study Investigators: Relation of insulin resistance to markers of preclinical cardiovascular disease: The Strong Heart Study. Nutr Metab Cardiovasc Dis 2003;13:140-147.
  • Devereux RB, Dahlöf B, Kjeldsen SE, Julius S, Aurup P, Beevers G, Edelman JM, de Faire U, Fyhrquist F, Berg SH, Ibsen H, Kristianson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Snapinn SM, Wedel H, for the LIFE study group: Cardiovascular morbidity and mortality in patients without pre-existing vascular disease in the Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study. Ann Intern Med 2003;139:169-177.
  • de Simone G, Devereux RB, Palmieri V, Bella JN, Oberman A, Kitzman DW, Hopkins PN, Rao DC, Arnett DK: Influence of fat-free mass on detection of appropriateness of left ventricular mass: The HyperGEN study. J Hypertens 2003;21:1747-1752.
  • Liu JE, Robbins DC, Palmieri V, Bella JN, Roman MJ, Fabsitz R, Howard BV, Welty TK, Lee ET, Devereux RB: Association of albuminuria with systolic and diastolic left ventricular dysfunction in type 2 diabetes: The Strong Heart Study. J Am Coll Cardiol 2003;41:2022-2028.
  • Palmieri V, Tracey RP, Roman MJ, Liu JE, Best LG, Bella JN, Robbins DC, Howard BV, Devereux RB: Relations of left ventricular hypertrophy to inflammation and albuminuria in adults with type 2 diabetes: The Strong Heart Study. Diabetes Care 2003;26:2764-2769.
  • Kristianson K, Fyhrquist F, Devereux RB, Kjeldsen SE, Lindholm LH, Lyle PA, Nieminen MS, Snapinn SM: An analysis of cholesterol control and statin use in the Losartan Intervention for Endpoint Reduction in Hypertension study. Clinical Therapeutics 2003;25:1186-1199.
  • Verdecchia P, Angeli F, Borgioni C, Gattobigio R de Simone G, Devereux RB, Porcellati C: Changes in cardiovascular risk by reduction of left ventricular mass in hypertension: a meta-analysis. Am J Hypertens 2003;16:897-899.
  • Roman MJ, Shanker BA, Davis A, Lockshin MD, Sammaritano L, Simantov R, Crow MK, Schwartz JE, Paget SA, Devereux RB, Salmon JE: Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med 2003;349:2399-2406.
  • Tang W, Devereux RB, Kitzman DW, Province MA, Leppert M, Oberman A, Hopkins PN, Arnett DK: The Arg17Gly polymorphism of the beta2-adrenergic receptor and left ventricular systolic function. Am J Hypertens 2003;16:945-951.
  • Olsen MH, Wachtell K, Tuxen E, Fossum E, Bang L, Hall C, Ibsen H, Rokkedal J, Devereux RB: N-terminal pro-brain natriuretic peptide predicts cardiovascular events in patients with hypertension and left ventricular hypertrophy: A LIFE substudy. J Hypertens 2004;22:1597-1604.
  • Okin PM, Devereux RB, Lee ET, Galloway JM, Howard BV: Electrocardiographic repolarization complexity and abnormality predict all-cause and cardiovascular mortality in diabetes: The Strong Heart Study. Diabetes 2004;53:434-440.
  • Resnick HE, Lindsay RS, McDermott MM, Devereux RB, Jones KL, Fabsitz RR, Howard BV: Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: The Strong Heart Study. Circulation 2004;109:733-739.
  • Li Z, Wachtell K, Okin PM, Gerdts E, Liu JE, Nieminen MS, Jern S, Dahlof B, Devereux RB: Association of left bundle branch block with left ventricular structure and function in hypertensive patients with left ventricular hypertrophy: The LIFE Study. J Hum Hypertens 2004;18:397-402.
  • Palmieri V, Wachtell K, Bella JN, Gerdts E, Papademetriou V, Nieminen MS, Dahlof B, Roman MJ, Devereux RB: Usefulness of the assessment of the appropriateness of left ventricular mass to detect left ventricular systolic and diastolic abnormalities in absence of echocardiographic left ventricular hypertrophy: The LIFE Study. J Hum Hypertens 2004;18:423-430.
  • Olsen MH, Wachtell K, de Simone G, Palmieri V, Dige-Petersen H, Devereux RB, Ibsen H, Rokkedal J: Is inappropriate left ventricular mass related to neurohormonal factors and/or arterial changes in hypertension? A LIFE Substudy. J Hum Hypertens 2004;18:437-443.
  • Wachtell K, Papademetriou V, Smith G, Gerdts E, Dahlöf B, Aalto T, Aurigemma GP, Bella JN, Fishman D, Ibsen H, Rokkedal J, Devereux RB: Relation of impaired left ventricular filling to systolic midwall mechanics in hypertensive patients with normal left ventricular systolic chamber function: The LIFE study. Am Heart J 2004;148:538-44.
  • Kontos J, Papademetriou V, Wachtell K, Palmieri V, Liu JE, Gerdts E, Boman K, Nieminen MS, Dahlof B, Devereux RB: Impact of valvular regurgitation on left ventricular geometry and function in hypertensive patients with left ventricular hypertrophy: the LIFE study. J Hum Hypertens 2004;18:431-436.
  • Wiinberg N, Bang LE, Wachtell K, Larsen J, Olsen MH, Tuxen C, Hildebrandt PR, Rokkedal J, Ibsen H, Devereux RB: 24-Hour ambulatory blood pressure in patients with ECG-determined left ventricular hypertrophy - left ventricular geometry and urine albumin excretion - a LIFE substudy. J Hum Hypertens 2004;18:391-396.
  • Bella JN, Palmieri V, Wachtell K, Liu JE, Gerdts E, Nieminen MS, Koren MJ, Zabalgoitia M, Wright JT, Dahlof B, Devereux RB: Sex-related difference in regression of left ventricular hypertrophy with antihypertensive treatment: the LIFE study. J Hum Hypertens 2004;18:411-416.
  • Devereux RB, Gerdts E, Wachtell K, Boman K, Nieminen MS, Papademetriou V, Rokkedal J, Harris KE, Edelman JM, Dahlof B: Regression of hypertensive left ventricular hypertrophy by losartan versus atenolol: The LIFE Study. Circulation 2004;110:1456-1462.
  • Gerdts E, Roman MJ, Palmieri V, Wachtell K, Smith G, Nieminen MS, Dahlof B, Devereux RB: The impact of age on left ventricular hypertrophy regression during antihypertensive treatment with losartan or atenolol (The LIFE Study). J Hum Hypertens 2004;18:417-422.
  • Kizer JR, Arnett DK, Bella JN, Paranicas M, Rao DC, Province MA, Oberman A, Kitzman DW, Hopkins PN, Liu JE, Roman MJ, Devereux RB: Racial-ethnic differences in left ventricular structure in hypertensive adults. The Hypertension Genetic Epidemiology Network (HyperGEN) Study. Hypertension 2004;43:1182-1188.
  • Dahlöf B, Burke TA, Krobot K, Carides GW, Edelman JM, Devereux RB, Diener HC: Population impact of losartan use on stroke in the European Union (EU) - Projections from the Losartan Intervention For Endpoint Reduction in hypertension (LIFE) Study. J Hum Hypertension 2004;18:367-373.
  • Oikarinen L, Nieminen MS, Viitasalo M, Toivonen L, Jern S, Dahlöf B, Devereux RB, Okin PM. QRS duration and QT interval predict mortality in hypertensive patients with left ventricular hypertrophy: the LIFE study. Hypertension 2004;43:1029-1034.
  • Maron BJ, Spirito P, Roman MJ, Paranicas M, Okin PM, Best LG, Lee ET, Devereux RB: Prevalence of hypertrophic cardiomyopathy in a population-based sample of middle-aged and elderly American Indians: The Strong Heart Study. Am J Cardiol 2004;93:1510-1514.
  • Okin PM, Devereux RB, Liu JE, Oikarinen L, Jern S, Kjeldsen SE, Julius S, Wachtell K, Nieminen MS, Dahlöf B, for the LIFE Study Investigators: Regression of electrocardiographic left ventricular hypertrophy predicts regression of echocardiographic left ventricular mass: The LIFE Study. J Hum Hypertens 2004;18:403-409.
  • Bella JN, MacCluer JW, Roman MJ, Almasy L, North KE, Best LG, Lee ET, Fabsitz RR, Howard BV, Devereux RB: Heritability of left ventricular dimensions and mass in American Indians: The Strong Heart Study. J Hypertens 2004;22:281-286.
  • Okin PM, Roman MJ, Lee ET, Galloway JM, Howard BV, Devereux RB. Combined echocardiographic left ventricular hypertrophy and electrocardiographic ST depression improve prediction of mortality in American Indians: The Strong Heart Study. Hypertension 2004; 43:769-774.
  • Julius S, Alderman MH, Beevers G, Dahlof B, Devereux RB, Douglas JG, Edelman JM, Harris KE, Kjeldsen SE, Nesbitt S, Randall OS, Wright JT Jr: Cardiovascular risk reduction in hypertensive black patients with left ventricular hypertrophy: The LIFE Study. J Am Coll Cardiol 2004;43:1047-1055.
  • de Simone G, Kitzman DW, Palmieri V, Liu JE, Oberman A, Hopkins PN, Bella JN, Rao DC, Arnett DK, Devereux RB: Association of inappropriate left ventricular mass with systolic and diastolic dysfunction: The HyperGEN Study. Am J Hypertens 2004;17:828-833.
  • Olsen MH, Wachtell K, Bella JN, Palmieri V, Gerdts E, Smith G, Nieminen MS, Dahlof B, Ibsen H, Devereux RB: Albuminuria predicts cardiovascular events independent of left ventricular mass in hypertension: a LIFE substudy. J Human Hypertens 2004;18:453-459.
  • Ibsen H, Wachtell K, Olsen MH, Borch-Johnsen K, Lindholm LH, Mogensen CE, Dahlof B, Devereux RB, Beevers G, de Faire U, Fyhrquist F, Julius S, Kjeldsen SE, Lederballe-Pedersen O, Nieminen MS, Okin PM, Omvik P, Oparil S, Wan Y, Snapinn SM, Wedel H: Does albuminuria predict cardiovascular outcome on treatment with losartan versus atenolol in hypertension with left ventricular hypertrophy? A LIFE substudy. J Hypertens 2004;22:1805-1811.
  • Okin PM, Devereux RB, Nieminen MS, Jern S, Oikarinen L, Viitasalo M, Toivonen L, Kjeldsen SE, Julius S, Snapinn S, Dahlof: Electrocardiographic strain pattern and prediction of cardiovascular morbidity and mortality in hypertensive patients. Hypertension 2004;44:48-54.
  • Devereux RB, Wachtell K, Gerdts E, Boman K, Nieminen MS, Papademetriou V, Rokkedal J, Snapinn SM, Aurup P, Dahlöf B: Prognostic significance of left ventricular mass change during treatment of hypertension: The LIFE study. JAMA 2004;292:2350-2356.
  • Reims HM, Oparil S, Kjeldsen SE, Devereux RB, Julius S, Brady WE, Fyhrquist F, Ibsen H, Lindholm LH, Omvik P, Wedel H, Beevers G, de Faire U, Kristianson K, Lederballe-Pedersen O, Nieminen M, Dahlof B, for the LIFE study group: Losartan benefits over atenolol in non-smoking hypertensive patients with left ventricular hypertrophy: The LIFE study. Blood Pressure 2004;13:376-384.
  • Olsen MH, Wachtell K, Bella JN, Liu JE, Boman K, Gerdts E, Papademetriou V, Nieminen MS, Rokkedal J, Dahlof B, Devereux RB: Effect of losartan versus atenolol on aortic valve sclerosis (a LIFE substudy). Am J Cardiol 2004;94:1076-1080.
  • Okin PM, Devereux RB, Jern S, Kjeldsen SE, Julius S, Nieminen MS, Snapinn S, Harris KE, Aurup P, Edelman JM, Wedel H, Lindholm LH, Dahlof B, for the LIFE Study Investigators: Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events: The LIFE study. JAMA 2004;292:2343-2349.
  • de Simone G, Kitzman DW, Chinali M, Oberman A, Hopkins PN, Rao DC, Arnett DK, Devereux RB: Left ventricular concentric geometry is associated with impaired relaxation in hypertension: The HyperGEN study. Eur Heart J 2005;26:1039-1045.
  • Boman K, Olofsson M, Dahlöf B, Gerdts E, Nieminen MS, Papademetriou V, Wachtell K, Devereux RB: Left ventricular structure and function in sedentary and physically active subjects with left ventricular hypertrophy - the LIFE Study. Am J Cardiol 2005;94:280-283.
  • Kizer JR, Dahlof B, Kjeldsen SE, Julius S, Beevers G, de Faire U, Fyhrquist F, Ibsen H, Kristianson K, Lederballe-Pedersen O, Lindholm LH, Nieminen M, Omvik P, Oparil S, Wedel H, Wachtell K, Edelman JM, Snapinn SM, Devereux RB: Stroke reduction in adult patients with cardiac hypertrophy randomized to losartan versus atenolol: The LIFE Study. Hypertension 2005;45:46-52.
  • Ibsen H, Olsen MH, Wachtell K, Borch-Johnsen K, Lindholm LH, Mogensen CE, Dahlöf B, Devereux RB, de Faire U, Fyhrquist F, Julius S, Kjeldsen SE, Lederballe-Pedersen O, Nieminen MS, Omvik P, Oparil S, Wan Y: Reduction in albuminuria during antihypertensive treatment translates to reduction in cardiovascular events in patients with hypertension and ECG-verified left ventricular hypertrophy. A LIFE Study. Hypertension 2005;45:198-202.
  • Olsen MH, Wachtell K, Bella JN, Gerdts E, Palmieri V, Nieminen M, Smith G, Ibsen H, Devereux RB: Aortic valve sclerosis relates to cardiovascular events in patients with hypertension (A LIFE substudy). Am J Cardiol 2005;95:132-136.
  • de Simone G, Daniels SR, Kimball TR, Roman MJ, Chinali M, Galderisi M, Devereux RB: Evaluation of concentric left ventricular geometry in humans: evidence for age-related systematic underestimation. Hypertension 2005;45:64-68.
  • Wachtell K, Lehto M, Gerdts E, Olsen MH, Hornestam B, Dahlöf B, Ibsen H, Julius S, Kjeldsen SE, Lindholm LH, Nieminen MS, Devereux RB. Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: The LIFE Study. J Am Coll Cardiol 2005;45:712-719.
  • Wachtell K, Hornestam B, Lehto M, Slotwiner DJ, Gerdts E, Aurup P, Dahlöf B, Ibsen H, Julius S, Kjeldsen SE, Nieminen MS, Rokkedal J, Devereux RB: Cardiovascular morbidity and mortality in hypertensive patients with atrial fibrillation: The LIFE study. J Am Coll Cardiol 2005;45:705-711.
  • Agno FS, Chinali M, Bella JN, Liu JE, Arnett DK, Kitzman DW, Oberman A, Hopkins PN, Rao DC, Devereux EB: Aortic valve sclerosis is associated with preclinical cardiovascular disease in hypertensive adults: The HyperGEN Study. J Hypertens 2005;23:867-873.
  • Fyhrquist F, Dahlof B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, de Faire U, Ibsen H, Kristianson K, Lederballe-Pedersen ), Lindholm LH, Nieminen MS, Omvik, P, Oparil S, Hille DA, Lyle PA, Edelman JM, Snapinn SM, Wedel H for the LIFE study group: Pulse pressure and treatment effects of losartan or atenolol in patients with hypertension and left ventricular hypertrophy: The LIFE study. Hypertension 2005;45:580-585.
  • Chinali M, de Simone G, Liu JE, Bella JN, Oberman A, Hopkins PN, Kitzman D, Rao DC, Arnett DK, Devereux RB: Left atrial systolic force and cardiac markers of pre-clinical disease in treated hypertensive patients: The HyperGEN study. Am J. Hypertens 2005;18:899-905.
  • de Simone G, Devereux RB, Chinali M, Best LG, Lee ET, Welty TK for the Strong Heart Study investigators: Association of blood pressure with blood viscosity in American Indians: The Strong Heart Study. Hypertension 2005;45:625-630.
  • Lynch AI, Arnett DK, Atwood LD, Devereux RB, Kitzman DW, Hopkins PN, Oberman A, Rao DC: A Genome Scan for Linkage with Aortic Root Diameter in Hypertensive African Americans and Whites in the HyperGEN Study. Am J Hypertens 2005;18:627-632.
  • de Simone G, Kizer JR, Chinali M, Roman MJ, Bella JN, Howard BV, Best L, Lee ET, Devereux RB, for the Strong Heart Study Investigators: Population attributable risk of left ventricular hypertrophy: impact of type of normalization for body size. Am J Hypertens 2005; 18(2 Pt 1):191-196.
  • de Simone G, Devereux RB, Kizer JR, Chinali M, Bella JN, Oberman A, Kitzman DW, Hopkins PN, Rao DC, Arnett DK: Body composition and fat distribution influence systemic hemodynamics in the absence of obesity: The HyperGEN study. Am J Clin Nutr 2005;81:757-761.
  • Olsen MH, Wachtell K, Tuxen C, Fossum E, Bang LE, Hall C, Ibsen H, Rokkedal J, Devereux RB, Hildebrandt PR: Opposite effects of losartan and atenolol on natriuretic peptides in patients with hypertension and left ventricular hypertrophy. A LIFE Substudy. J Hypertens 2005;23:1083-1090.
  • de Simone G, Roman MJ, Alderman MH, Galderisi M, de Divitiis O, Devereux RB: Is high pulse pressure a marker of preclinical cardiovascular disease? Hypertension 2005; 45:575-579.
  • Howard BV, Devereux RB, Cole SA, Davidson M, Dyke B, Ebbesson SOE, Epstein SE, Robinson DR, Jarvis B, Kaufman DJ, Laston S, McCluer JW, Okin PM, Roman MJ, Romanesko T, Ruotolo G, Swenson M, Wenger CR, Williams-Blangero S, Zhu J, Saccheus C, Fabsitz RR, Robbins DC: A Genetic and Epidemiologic Study of Cardiovascular Disease in Alaska Natives (GOCADAN): Design and Methods. Int J Circumpolar Health 2005;64:206-221.
  • Nobmann ED, Ponce R, Mattil C, Devereux R, Dyke B, Ebbesson SOE, Laston S, MacCluer J, Robbins D, Romanesko T, Ruotolo G, Wenger CR, Howard BV: Dietary intakes vary with age among Eskimo adults of northwest Alaska in the GOCADAN Study, 2000-2003. J Nutrition 2005;135:856-862.
  • de Simone G, Wachtell K, Palmieri V, Hille DA, Beevers G, Dahlof B, de Faire U, Fyhrquist F, Ibsen H, Julius S, Kjeldsen SE, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Devereux RB: Body build and risk of cardiovascular events in hypertension: The LIFE study. Circulation 2005;111:1924-1931.
  • Hildebrandt P, Dahlöf B, Papademetriou V, Gerdts E, Giles T, Oikarinen L, Tuxen C, Wachtell K, Devereux RB. Impairment of cardiac function in hypertensive patients with type 2 diabetes. A LIFE study. Diabetic Medicine 2005;22:1005-1011.
  • Okin PM, Roman MJ, Best LG, Lee ET, Galloway JM, Howard BV, Devereux RB: C-reactive protein and electrocardiographic ST-segment depression additively predict mortality: The Strong Heart Study. J Am Coll Cardiol 2005;45:1787-1793.
  • Roman MJ, Devereux RB, Schwartz JE, Lockshin MD, Paget SA, Davis A, Crow MK, Sammaritano L, Levine DM, Shankar BA, Moeller E, Salmon JE: Arterial stiffness in chronic inflammatory diseases. Hypertension 2005;46:194-199.
  • Best LG, Zhang Y, Lee ET, Yeh J-L, Cowna L, Palmieri V, Roman M, Devereux RB, Fabsitz RR, Tracy RP, Robbins D, Davidson M, Ahmed A, Howard BV: C-reactive protein as a predictor of cardiovascular risk in a population with a high prevalence of Diabetes: The Strong Heart Study. Circulation 2005;112:1289-1295.
  • Kjeldsen SE, Lyle PA, Kizer JR, Dahlof B, Devereux RB, Julius S, Beevers G, de Faire U. The Effects of Losartan Compared to Atenolol on Stroke in Patients With Isolated Systolic Hypertension and Left Ventricular Hypertrophy. The LIFE Study. J Clin Hypertens (Greenwich) 2005;7:152-8.
  • Okin PM, Malik M, Hnatkova K, Lee ET, Galloway JM, Best LG, Howard BV, Devereux RB: Repolarization Abnormality for Prediction of All-Cause and Cardiovascular Mortality in American Indians: The Strong Heart Study. J Cardiovasc Electrophysiol 2005;16:945-951.
  • Tang W, Arnett DK, Devereux RB, Panagiotou D, Province MA, Gu C, de Simone G, Ferrell RE: Identification of a novel 5-bp deletion in calcineurin B (PPP3R1) promoter region and its association with left ventricular hypertrophy. American Heart J 2005;150:845-851.
  • Olsen MH, Christensen MK, Wachtell K, Tuxen C, Fossum E, Bang LE, Wiinberg N, Devereux RB, Kjeldsen SE, Hildebrandt P, Dige-Petersen H, Rokkedal J, Ibsen H: Markers of collagen synthesis is related to blood pressure and vascular hypertrophy: A LIFE substudy. J Hum Hypertens 2005;19:301-307.
  • Fossum E, Moan A, Kjeldsen SE, Devereux RB, Julius S, Snapinn SM, Edelman JM, de Faire U, Fyhrquist, Ibsen H, Kristianson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H, Dahlöf B: The effect of losartan versus atenolol on cardiovascular morbidity and mortality in patients with hypertension taking aspirin: The LIFE Study. J Am Coll Cardiol 2005;46:770-775.
  • Stein KM, Devereux RB, Hahn RT, Markowitz SM, Mittal S, Iwai S, Lerman BB: Effect of Transthoracic Shocks on Left Ventricular Function. Resuscitation 2005;66:309-315.
  • de Simone G, Devereux RB, Maggioni AP, Gorine M, de Divitiis O, Verdecchia P: Different normalizations for body size and population attributable risk of left ventricular hypertrophy: the MAVI study. Am J Hypertens 2005;18:1288-1293.
  • Olsen MH, Wachtell K, Bella JN, Palmieri V, Gerdts E, Smith G, Nieminen MS, Dahlöf B, Ibsen H, Devereux RB: Aortic valve sclerosis and albuminuria predict cardiovascular events independently in hypertension: a Losartan Intervention For Endpoint reduction in hypertension (LIFE) substudy. Am J Hypertens 2005;18:1430-1436.
  • Chinali M, de Simone G, Roman MJ, Bella JN, Liu JE, Lee ET, Best LG, Howard BV, Devereux RB: Left atrial systolic force and cardiovascular outcome: The Strong Heart Study. Am J Hypertens 2005;18:1570-1576.
  • Franklin SS, Wachtell K, Papadimitriou V, Olsen MH, Devereux RB, Fyhrquist F, Ibsen H, Kjeldsen SE, Dahlöf: Effect of losartan compared to atenolol on cardiovascular mortality and morbidity in higher and lower risk patients with hypertension and left ventricular hypertrophy -The LIFE Study. Hypertension 2005;46:492-499. Carr AA, Kowey PR, Devereux RB, Brenner BM, Dahlöf B, Ibsen H, Lindholm LH, Lyle PA, Snapinn SM, Zhang Z, Edelman JM, Shahinfar S: The Effect of Losartan on Hospitalizations for New Heart Failure Among Subjects with Diabetes Mellitus: The RENAAL and LIFE studies. Am J Cardiol 2005;96:1530-1536.
  • Kizer JR, Wiebers DO, Whisnant JP, Galloway JM, Welty TK, Lee ET, Best LG, Resnick HE, Roman MJ, Devereux RB: Mitral annular calcification, aortic-valve sclerosis and incident stroke in adults free of clinical cardiovascular disease: The Strong Heart Study. Stroke 2005;36:2533-2537.
  • Kizer JR, Devereux RB: Clinical practice. Patent foramen ovale in young adults with unexplained stroke. N Engl J Med 2005;353:2361-2372.
  • Rasmussen-Torvik LJ, North KE, Gu CC, Lewis CE, Wilk JB, Chakravarti A, Chang Y-PC, Miller MB, Li N, Devereux RB, Arnett DK: A population association study of angiotensin polymorphisms and haplotypes with left ventricular phenotypes. Hypertension 2005;46:1530-1535.
  • Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise J, Solomon SD, Spencer KT, St. John Sutton M, Stewart WJ; Members of the Chamber Quantification Writing Group: Recommendations for Chamber Quantification. A report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the American College of Cardiology Echocardiography Committee, the American Heart Association, and the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005;18:1440-1463.
  • Okin PM, Devereux RB, Nieminen MS, Jern S, Oikarinen L, Viitasalo M, Toivonen L, Kjeldsen SE, Dahlöf B, for the LIFE Study Investigators: Electrocardiographic strain pattern and prediction of new-onset congestive heart failure in hypertensive patients: The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Study. Circulation 2006;113:67-73.
  • de Simone G, Devereux RB, Chinali M, Roman MJ, Best LG, Welty TK, Lee ET, Howard BV for the Strong Heart Study Investigators: Risk factors for arterial hypertension in adults with initial optimal blood pressure: The Strong Heart Study. Hypertension 2006;47:1-7.
  • Olsen MH, Wachtell K, Dahlöf B, Devereux RB, Ibsen H, Kjeldsen SE, Lindholm LH, Lyle PA, Nieminen M: The effect of losartan compared with atenolol on the incidence of revascularization in patients with hypertension and electrocardiographic left ventricular hypertrophy. The LIFE study. J Hum Hypertens 2006;20:460-4.
  • Pini R, MD, Cavallini MC, Staglianò L, Tarantini F, Marchionni N, Di Bari M, Devereux RB, Masotti G, Roman MJ: Blood Pressure Normalization Is Associated with Normal Left Ventricular Mass but not Carotid Geometry: The ICARe Dicomano Study. J Hypertens 2006;24:973-79.
  • Zhang Y, Lee ET, Devereux RB, Yeh JL, Best LG, Fabsitz RR, Howard BV: Prehypertension, diabetes and cardiovascular disease risk in a population-based sample: The Strong Heart Study. Hypertension 2006;47:410-14.
  • Kizer JR, Bella JN, Palmieri V, Liu JE, Best LG, Lee ET, Roman MJ, Devereux RB: Left atrial diameter as an independent predictor of first clinical cardiovascular events in middle-aged and elderly adults: The Strong Heart Study. Am Heart J 2006;151:412-418.
  • Tang W, Arnett DK, Province MA, Lewis CE, North K, Carr JJ, Pankow JS, Hopkins PN, Devereux RB, Wilk JB, Wagenkecht L: Racial Differences in the Association of Coronary Calcified Plaque with Left Ventricular Hypertrophy: The NHLBI Family Heart Study and Hypertension Genetic Epidemiology Network Study. Am J Cardiol 2006;97:1441-48.
  • Carter E, MacCluer JW, Dyke B, Howard BV, Devereux RB, Ebbesson SOE, Resnick HE: Diabetes mellitus and impaired fasting glucose in Alaskan Eskimos. Diabetologia 2006;49:29-35.
  • Ebbesson SOE, Laston S, Wenger CR, Dyke B, Romenesko T, Swenson M, Fabsitz R, MacCluer JW, Devereux R, Roman M, Robbins D, Howard BV: Recruitment and community interactions in the GOCADAN study. Int J Circumpolar Health 2006;65:55-64.
  • Roman MJ, Moeller E, Davis A, Paget SA, Crow MK, Lockshin MD, Sammaritano L, Devereux RB, Schwartz JE, Levine D, Salmon JE: Premature carotid atherosclerosis in patients with rheumatoid arthritis: Prevalence and associated factors. Ann Intern Med 2006;144:249-56.
  • Howard WJ, Jones K, Lee ET, Ratner RE, Resnick HE, Devereux RB: Coronary heart disease risk equivalence in diabetes depends on concomitant risk factors. Diabetes Care 2006;29:391-7.
  • Narayan P, Papademetriou V, Wachtell K, Gerdts E, Boman K, Nieminen MS, de Simone G, Dahlöf B, Fyhrquist F, Hoieggen A, Devereux RB: Association of hemoglobin delivery with left ventricular structure and function in hypertensive patients with left ventricular hypertrophy: The LIFE Study. Hypertension 2006;47:868-73.
  • Al’absi M, Devereux RB, Rao DC, Kitzman D, Oberman A, Hopkins P, Arnett DK: Blood pressure stress reactivity and left ventricular mass in a random community sample of African-American and Caucasian men and women. Am J Cardiol 2006;97:240-244.
  • Olsen ME, Wachtell K, Ibsen H, Lindholm LH, Dahlof B, Devereux RB, Kjeldsen SE, Oikarinen L, Okin PM: Reductions in albuminuria and in electrocardiopgrahic left ventricular hypertrophy independendly improve prognosis in hypertension. The Life Study. J Hypertens 2006;24:775-81.
  • Okin PM, Gerdts E, Snapinn SM, Harris KE, Jern S, Kjeldsen SE, Devereux RB: The impact of diabetes on regression of electrocardiographic left ventricular hypertrophy and the prediction of outcome during antihypertensive therapy: The LIFE Study. Circulation 2006;113:1588-96.
  • Voruganti VS, Cai G, Cole SA, Freeland-Graves JH, Laston S, Wenger CR, MacCluer JW, Dyke B, Devereux R, Ebbesson SO, Fabsitz RR, Howard BV, Comuzzie AG: A common set of genes regulates LDL size and obesity-related factors in Alaskan Eskimos: Results from the GOCADAN study. Am J Hum Biol 2006;18:525-31.
  • Bella JN, Palmieri V, Roman MJ, Paranicas M, Welty TK, Lee ET, Fabsitz RR, Howard BV, Devereux RB for the Strong Heart Study Investigators: Gender differences in left ventricular systolic function in American Indians: The Strong Heart Study. Am J Cardiol 2006;98:834-7.
  • Olsen MH, Wachtell K, Nielsen OW, Hall C, Wergeland R, Ibsen H, Kjeldsen SE, Devereux RB, Dahlöf B, Hildebrandt PR: N-terminal brain natriuretic peptide predicted cardiovascular events stronger than high sensitivity C-reactive protein in hypertension. A LIFE Substudy. J Hypertens 2006;24:1531-9.
  • Okin PM, Wachtell K, Devereux RB, Harris KE, Jern S, Kjeldsen SE, Julius S, Lindholm LH, Nieminen MS, Edelman JM, Dahlöf B: Regression of electrocardiographic left ventricular hypertrophy and decreased incidence of new-onset atrial fibrillation in hypertensive patients: The LIFE Study. JAMA 2006;296:1242-8.
  • Chinali M, de Simone G, Roman MJ, Lee ET, Best LG, Howard BV, Devereux RB: Impact of obesity on cardiac geometry and function in a population of adolescents: The Strong Heart Study. J Am Coll Cardiol 2006;47:2267-73.
  • Wang W, Lee ET, Fabsitz RR, Devereux R, Best L, Welty TK, Howard BV: A longitudinal study of hypertension risk factors and their relation to cardiovascular disease. Hypertension 2006;47:403-409.
  • Palmieri V, Okin PM, Bella JN, Wachtell K, Gerdts E, Boman K, Nieminen MS, Dahlöf B, Devereux RB: Electrocardiographic strain pattern and left ventricular diastolic function in hypertensive patients with left ventricular hypertrophy: The LIFE Study. J Hypertens 2006;24:2079-2084.
  • Diego VP, Goring HH, Cole SA, Almasy L, Dyer TD, Blangero J, Duggirala R, Laston S, Wenger C, Cantu T, Dyke B, North K, Schurr T, Best LG, Devereux RB, Fabsitz RR, Howard BV, Maccluer JW: Fasting insulin and obesity-related phenotypes are linked to chromosome 2p: The Strong Heart Family Study. Diabetes 2006;55:1874-1878.
  • Palmieri V, Devereux RB, Hollywood J, Bella JN, Liu JE, Lee ET, Best LG, Howard BV, Roman MJ: Association of pulse pressure with cardiovascular outcome is independent of left ventricular hypertrophy and systolic dysfunction: the strong heart study. Am J Hypertens. 2006;19:601-7.
  • Lee ET, Howard BV, Wang W, Welty TK, Galloway JM, Best LG, Fabsitz RR, Zhang Y, Yeh JL, Devereux RB: Prediction of coronary heart disease in a population with high prevalences of diabetes and albuminuria: The Strong Heart Study. Circulation 2006;113:2897-905.
  • Gerdts E, Björnstad H, Devereux RB, Lund-Johansen P, Davidsen ES, Omvik P: Exercise performance during antihypertensive treatment with losartan or atenolol in hypertensive patients with electrocardiographic left ventricular hypertrophy (a LIFE substudy). Blood Press 2006;15:220-226.
  • Christensen MK, Olsen MH, Wachtell K, Tuxen C, Fossum E, Gang LE, Wiinberg N, Devereux RB, Kjeldsen SE, Hildebrandt P, Rokkedal J, Ibsen H: Does long-term losartan- vs atenolol-based antihypertensive treatment influence collagen markers differently in hypertensive patients? A LIFE substudy. Blood Press 2006;15:198-206.
  • Gerin W, Schwartz JE, Devereux RB, Goyal T, Shimbo D, Ogedegbe G, Rieckmann N, Abraham D, Chaplin W, Burg M, Jhulani J, Pickering TG: Superiority of ambulatory to physician blood pressure is not an artifact of differential blood pressure reliability. Blood Press Monitor 2006;11:297-301.
  • Rhoades DA, Welty TK, Wang W, Yeh F, Devereux RB, Fabsitz RR, Lee ET, Howard BV: Aging and the prevalence of cardiovascular disease risk factors among older American Indians: The Strong Heart Study. J Am Geriatr Soc 2007;55:87-94.
  • Mishra RK, Kizer J, Palmieri V, Roman MJ, Galloway JM, Fabsitz RR, Lee ET, Best LG, Devereux RB: Utility of the myocardial performance index in a population with high prevalences of obesity, diabetes and hypertension: the Strong Heart Study. Echocardiography 2007;24:340-347.
  • Drukteinis JS, Roman MJ, Fabsitz RR, Lee ET, Best LG, Russell M, Devereux RB : Cardiac and systemic hemodynamic characteristics of hypertension and prehypertension in adolescents and young adults: The Strong Heart Study. Circulation 2007;115:221-7; [Epub 1/8].
  • Eijkelkamp WBA, Zhang Z, BrennerBM, Devereux RB, Dahlöf B, Ibsen H, Lindholm LH, Olsen MH, Parving H-H, Shahinfar S, Wachtell K, de Zeeuw D: Renal function and risk for cardiovascular events in patients with type 2 diabetes: The RENAAL and LIFE Studies. J Hypertens 2007;25:871-876.
  • Xu J, Knowler WC, Devereux RB, Yeh JL, Umans JG, Begum M, Fabsitz RR, Lee ET: Albuminuria within the “normal” range and risk of cardiovascular disease and death in American Indians: The Strong Heart Study. Am J Kidney Dis 2007;49:208-216.
  • Devereux RB, de Faire U, Fyhrquist F, Harris KE, Ibsen H, Kjeldsen SE, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H, Hille D, Dahlöf B: Blood pressure reduction and antihypertensive medication use in the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy. Curr Med Res Opin 2007; 23:259-270.
  • Gerdts E, Wachtell K, Omvik P, Otterstad JE, Oikarinen L, Boman K, Dahlöf B, Devereux RB: Left atrial size and risk of major cardiovascular events during antihypertensive treatment. The LIFE Trial. Hypertension 2007;49:311-316.
  • Farzaneh-Far F, Roman MJ, Lockshin MD, Devereux RB, Paget SA, Crow MK, Davis A, Sammaritano L, Levine DA, Salmon JE: Relation of antiphospholipid antibodies to cardiovascular manifestations of systemic lupus erythematosus. Arthritis Rheum 2006;54:3918-3925.
  • Bella JN, Arnett DK, Tang W, Kraja A, Rao DC, Hunt SC, Palmieri V, Miller M, Oberman A, Kitzman DW, Roman MJ, Devereux RB: Genome-wide linkage mapping for valve calcification susceptibility loci in hypertensive sibships: The HyperGEN Study. Hypertension 2007;49:453-460.
  • Meyers KJ, Mosley TH, Fox E, Boerwinkle E, Arnett DK, Devereux RB, Kardia SLR: Genetic variations associated with echocardiographic left ventricular traits in hypertensive African-Americans. Hypertension 2007;49:992-999.
  • Palmieri V, Okin PM, de Simone G, Bella JN, Wachtell K, Gerdts E, Boman K, Nieminen MS, Dahlöf B, Devereux RB: Electrocardiographic characteristics and metabolic risk factors associated with inappropriately high left ventricular mass in patients with electrocardiographic left ventricular hypertrophy: The LIFE Study. J Hypertens 2007;25:1079-1085.
  • Sherva R, Miller MB, Lynch AI, Devereux RB, Rao DC, Oberman A, Hopkins PN, Kitzman DW, Atwood LD, Arnett DK: A whole genome scan for pulse pressure/stroke volume ratio in African Americans: The HyperGEN Study. Am J Hypertens 2007;20:398-402.
  • de Simone G, Devereux RB, Chinali M, Best LG, Lee ET, Galloway JM, Resnick HE for the Strong Heart Study Investigators: Prognostic impact of metabolic syndrome by different definitions in a population with high prevalence of obesity: The Strong Heart Study. Diabetes Care 2007; 30:1851-6; [Epub 4/17].
  • Dahlöf B, Devereux RB, Kjeldsen SE, Lyle PA, Zhang Z, Edelman JM: Atenolol as a comparator in outcome trials in hypertension: a correct choice in the past, but not for the future? Blood Press 2007;16:6-12.
  • Min JK, Shaw LJ, Devereux RB, Okin PM, Weinsaft JW, Russo DJ, Lippolis NJ, Berman DS, Callister TQ: Prognostic value of multidetector coronary CT angiography for prediction of all-cause mortality. J Am Coll Cardiol 2007;50:1161-70.
  • Cicala S, de Simone G, Roman MJ, Best LG, Lee ET, Welty TG, Galloway JM, Howard BV, Devereux RB: Prevalence and prognostic significance of wall motion abnormalities in adults without recognized cardiovascular disease: The Strong Heart Study. Circulation 2007; 116:143-50; [E-pub 6/18].
  • Fossum E, Gleim GW, Kjeldsen SE, Kizer JR, Julius S, Devereux RB, Brady WE, Hille DA, Lyle PA, Dahlöf B: The effect of baseline physical activity on cardiovascular outcomes and new-onset diabetes in patients treated for hypertension and left ventricular hypertrophy: The LIFE Study. J Intern Med 2007;262:439-448.
  • de Simone G, Tang W, Devereux RB, Hunt SC, Kitzman DW, Rao D, Arnett DK: Assessment of the interaction of heritability of volume load and left ventricular mass: The HyperGEN offspring study. J Hypertens 2007;25:1397-1402.
  • Cicala S, Devereux RB, de Simone G, Wachtell K, Gerdts E, Boman K, Nieminen MS, Papademetriou V, Dahlöf B, Okin PM: Electrocardiographic or echocardiographic detection of myocardial infarction in patients with left ventricular hypertrophy: The LIFE Study. Am J Hypertens 2007;20:771-6.
  • Karas MG, Francescone S, Segal AZ, Devereux RB, Roman MJ, Liu JE, Hahn RT, Kizer JR: Relationship between mitral annular calcification and complex aortic atheroma in patients with cerebral ischemia referred for transesophageal echocardiography. Am J Cardiol 2007; 99:1306-11; [Epub March 20].
  • de Simone G, Olsen MH, Wachtell K, Hille DA, Dahlöf B, Ibsen H, Kjeldsen SE, Lyle PA, Devereux RB: Clusters of metabolic risk factors predict cardiovascular events in hypertension with target-organ damage: the LIFE study. J Hum Hypertens 2007; 21:625-32 [Epub May 3].
  • Pieretti J, Roman MJ, Devereux RB, Lockshin MD, Crow MK, Paget SA, Schwartz JE, Sammaritano L, Levine DM, Salmon JE: Systemic lupus erythematosus predicts increased left ventricular mass. Circulation 2007; 116:419-26; [Epub 7/9].
  • Okin PM, Roman MJ, Lee ET, Galloway JM, Best LG, Howard BV, Devereux RB: Usefulness of quantitative assessment of electrocardiographic ST depression for predicting new-onset heart failure in American Indians (From the Strong Heart Study). Am J Cardiol 2007;100:94-98; [Epub May 15].
  • Roman MJ, Devereux RB, Kizer JR, Lee ET, Galloway JM, Ali T, Fabsitz RR, Henderson JA, Howard BV: Central aortic pressure is more strongly related to vascular disease and to outcome than is brachial pressure: The Strong Heart Study. Hypertension 2007; 50:197-203; [May 7 Epub].
  • Roman MJ, Crow MK, Lockshin MD, Devereux RB, Lockshin MD, Paget SA, Sammaritano L, Levine DM, Davis A, Salmon JE: Rate and determinants of progression of atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 2007; 56:3412-19; [Epub 9/28].
  • Eguchi K, Schwartz JE, Roman MJ, Devereux RB, Gerin W, Pickering TG: Metabolic syndrome less strongly associated with target organ damage than syndrome components in a healthy, working population. J Clin Hypertens 2007;9:337-44.
  • Smebye ML, Iversen EK, Høieggen A, Flaa A, Os I, Kjeldsen SE, Olsen MH, Chattopadhyay A, Hille DA, Lyle PA, Devereux RB, Dahlöf B: Effect of hemoglobin levels on cardiovascular outcomes in patients with isolated systolic hypertension and left ventricular hypertrophy: the LIFE study. Am J Cardiol 2007; 100:855-9 [Epub July 7].
  • Okin, PM, Devereux RB, Harris KE, Jern S, Kjeldsen SE, Julius S, Edelman JM, Dahlof B: Regression of electrocardiographic left ventricular hypertrophy and decreased incidence of new-onset heart failure in hypertensive patients: The LIFE Study. Ann Intern Med 2007; 147:311-9.
  • Lacro RV, Dietz HC, Wruck LM, Bradley TJ, Colan SD, Devereux RB, Klein GL, Li JS, Minich LL, Paridon SM, Pearson GD, Printz BF, Pyeritz RE, Radojewski E, Roman MJ, Saul JP, Stylianou MP, Mahony L; Pediatric Heart Network Investigators: Rationale and design of a randomized clinical trial of beta-blocker therapy (atenolol) versus angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome. Am Heart J 2007;154:624-31.
  • Wachtell K, Okin PM, Olsen MH, Dahlöf B, Devereux RB, Ibsen H, Kjeldsen SE, Lindholm LH, Nieminen MS, Thygesen K: Regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy and reduction in sudden cardiac death: The LIFE Study. Circulation 2007; 116:700-5 [Epub 7/30].
  • Okin PM, Devereux RB, Harris KE, Jern S, Kjeldsen SE, Lindholm LH, Dahlof B: LIFE Study Investigators: In-treatment resolution or absence of electrocardiographic left ventricular hypertrophy is associated with decreased incidence of new-onset diabetes mellitus in hypertensive patients. The LIFE Study. Hypertension 2007;50:984-90 [Epub 9/24].
  • Mishra RK, Galloway JM, Lee ET, Best LG, Roman MJ, Devereux RB: The ratio of mitral deceleration time to E-wave velocity and mitral deceleration slope outperform deceleration time alone in predicting cardiovascular outcomes: the Strong Heart Study. J Am Soc Echocardiogr 2007;20:1300-6 [Epub June 22].
  • Casale SN, Auster CJ, Wolf F, Pei Y, Devereux RB: Ethnicity and socioeconomic status influence use of primary angioplasty in patients presenting with acute myocardial infarction. Am Heart J 2007; 154:989-993.
  • Ebbesson SO, Tejero ME, Nobmann ED, Lopez-Alvarenga JC, Ebbesson L, Romenesko T, Carter EA, Resnick HE, Devereux RB, MacCluer JW, Dyke B, Laston SL, Wenger CR, Fabsitz RR, Comuzzie AG, Howard BV: Fatty acid consumption and metabolic syndrome components: The GOCADAN Study. J Cardiometab Syndr 2007;2:244-249.
  • Palmieri V, Roman MJ, Bella JN, Liu JE, Best LG, Lee ET, Howard BV, Devereux RB : Prognostic implications of relations of left ventricular systolic dysfunction with body composition and myocardial energy expenditure: The Strong Heart Study. J Am Soc Echocardiogr 2008;21:66-71;[Epub July10].
  • Djoussé L, Kochar J, Hunt SC, North KE, Gu CC, Tang W, Arnett DK, Devereux RB: Relation of albuminuria to left ventricular mass (from the HyperGEN Study). Am J Cardiol 2008;101:212-216.
  • Weinsaft JW, Cham MD, Janik M, Min JK, Henschke CI, Yankelevitz DF, Devereux RB: Left ventricular papillary muscles and trabeculae are significant determinants of cardiac MRI measurements: Effects on clinical standards in patients with advanced systolic dysfunction. Int J Cardiol 2008; [Epub Aug 13](in press).
  • Lin F, Shaw LJ, Berman DS, Callister TQ, Weinsaft JW, Wong FJ, Szulc M, Tandon V, Okin PM, Devereux RB, Min JK: Multidetector computed tomography coronary artery plaque predictors of stress-induced myocardial ischemia by SPECT. Atherosclerosis 2008; [Epub 8/24/07] (in press).
  • Ebbesson SO, Roman MJ, Devereux RB, Kaufman D, Fabsitz RR, MacCluer JW, Dyke B, Laston S, Wenger CR, Comuzzie AG, Romenesko T, Ebbesson LO, Nobmann ED, Howard BV: Consumption of omega-3 fatty acids is not associated with a reduction in carotid atherosclerosis. The Genetcs of Coronary Artery Disease in Alaska Natives Study. Atherosclerosis 2008; Dec 3 [Epub] (in press).
  • Kaufman, DJ, Roman MJ, Devereux RB, Fabsitz RR, MacCluer JW, Dyke B, Ebbesson SOE, Gutman K, Wenger CR, Romanesko T, Comuzzie AG, Howard BV: Prevalence of smoking and its relationship with carotid atherosclerosis in Alaskan Eskimos of the Norton Sound region: The GOCADAN Study. Nicotine and Tobacco Res J 2008; (in press).
  • Honors and Awards

    1971   Recipient, Dr. Spencer Morris Prize "to the medical student of the graduating class who shall pass the best examination for the degree of Doctor of Medicine."

    1978   Army Commendation Medal

    1980-82   Andrew W. Mellon Teacher-Scientist Award

    1985-87   Director, American Society of Echocardiography.

    1987   Antoine Marfan Research Award, National Marfan Foundation

    1993-98 Chair, Professional Advisory Board, National Marfan Foundation

    1996-98 Chair, Epidemiology and Disease Control-1 Study Section, National Institutes of Health

    1999-01   President, New York Society of Echocardiography

    2003   Hero with a Heart Award, National Marfan Foundation and New York Heart Association

    2005 Co-Chair, American College of Cardiology Meeting